Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms
about
Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype scoreMolecular genetics of successful smoking cessation: convergent genome-wide association study resultsA central resource for accurate allele frequency estimation from pooled DNA genotyped on DNA microarraysPPC: an algorithm for accurate estimation of SNP allele frequencies in small equimolar pools of DNA using data from high density microarrays.Genetic research on nicotine dependence will facilitate public healthAdolescent Alcohol Exposure: Burden of Epigenetic Reprogramming, Synaptic Remodeling, and Adult PsychopathologyRole of mitochondria in alcoholic liver diseaseNrCAM in addiction vulnerability: positional cloning, drug-regulation, haplotype-specific expression, and altered drug reward in knockout miceComorbid alcohol and nicotine dependence: from the biomolecular basis to clinical consequences.Genome-wide linkage scan for nicotine dependence in European Americans and its converging results with African Americans in the Mid-South Tobacco Family sample.Ethanol-BDNF interactions: still more questions than answers.Genetic influences in emotional dysfunction and alcoholism-related brain damageMatrix Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma."Higher order" addiction molecular genetics: convergent data from genome-wide association in humans and mice.MPDA: microarray pooled DNA analyzer.Genome wide association for substance dependence: convergent results from epidemiologic and research volunteer samples.Genome wide association for addiction: replicated results and comparisons of two analytic approachesGPFrontend and GPGraphics: graphical analysis tools for genetic association studies.Escalating ethanol intake is associated with altered corticostriatal BDNF expressionHeritability and a genome-wide linkage analysis of a Type II/B cluster construct for cannabis dependence in an American Indian communityEndogenous BDNF in the dorsolateral striatum gates alcohol drinking.Pooled association genome scanning: validation and use to identify addiction vulnerability loci in two samples.Genomic regions identified by overlapping clusters of nominally-positive SNPs from genome-wide studies of alcohol and illegal substance dependenceAssociation between Val66Met brain-derived neurotrophic factor (BDNF) gene polymorphism and post-treatment relapse in alcohol dependence.Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding.Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction.Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence.Implications of genome wide association studies for addiction: are our a priori assumptions all wrong?Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent.BDNF Val66Met variant and smoking in a Chinese population.Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: candidate gene variants for addictionsAssociation between gene polymorphisms of SLC22A3 and methamphetamine use disorder.Genome-wide association for smoking cessation success: participants in the Patch in Practice trial of nicotine replacement.Genomewide linkage scan for opioid dependence and related traitsNeurexin 3 polymorphisms are associated with alcohol dependence and altered expression of specific isoforms.Ethanol-induced increases in extracellular dopamine are blunted in brain-derived neurotrophic factor heterozygous mice.The role of amygdaloid brain-derived neurotrophic factor, activity-regulated cytoskeleton-associated protein and dendritic spines in anxiety and alcoholismStructural and functional modifications in glutamateric synapses following prolonged ethanol exposureDNA Pooling: a tool for large-scale association studies.Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment
P2860
Q24621065-A746CD11-2C82-4292-9809-6D887B5F79FAQ24653819-50EE844B-CD38-4816-BA43-D71F4A75DC08Q24791896-94B9C63A-5287-4805-AA20-3FBDA3FA49CEQ24810725-10A0689C-0E41-43CE-AF5F-61BBAD4BE6D2Q24812595-CB340FCC-9D8C-4FDE-B6A5-5BF9000CA817Q26746053-310B79B2-81DB-4FF4-A379-574AF64340EFQ26864954-E6350181-7B87-42F4-915F-6A3CB318D0BFQ28269117-30EAC2AB-575E-4FEF-B94A-3F402D381F21Q30438012-3E2A2E17-5C51-43B6-9F83-4E56F4374B57Q30443885-A1F6185C-EFC3-4A58-8A13-F3FFCB74FB70Q30490427-E5822D30-6C47-456E-AF4E-9FBDBCFCEFA8Q30494163-7ACFBB1F-7CFF-4BC5-938F-54A8C2DA3669Q33277424-01A7CAC0-D2CE-4743-85EE-AE77941B86F5Q33296351-EB41E0E6-2686-41ED-A201-A5FC88351DA2Q33328303-8C7793AE-FA05-4347-8DD4-AED34BD26B1FQ33394394-42E05808-D8C3-401A-B836-7981ED73BE03Q33526292-88BC0588-4140-4C0B-B5E2-47632EF69C86Q33698621-323B1A02-EE46-4484-B6E9-B6A5DEAC01AEQ33760989-7FBFD4D4-CD0D-42D0-BF70-572BA465DC0AQ33772486-CC82695A-3DCA-4EC6-BA19-CF146D178F84Q33793424-9BD02AEA-DC12-4AD4-BBDA-16CD7DBEC5DAQ33913714-0272B380-DED5-4653-84F4-9CA5DE1A5638Q33982861-84DBD3A8-8B09-446B-AC0D-4F152C6BDF6FQ34085837-7212BFE7-CE59-43F6-90C8-007B3AF87A73Q34110230-57934871-30FB-457B-8DE7-A9DC0B5AB895Q34118780-A1F01B30-A6E4-4139-94CA-9453E592CB4DQ34139876-30AFC8B0-C906-4A5B-B884-889A6AAB62AEQ34358797-BB510AB3-0D89-49DE-A3FE-49E096B2D048Q34410506-ACA8B429-E2E4-4766-9589-31288F2FF9AFQ34535122-6A334A78-6C98-40A0-A3DF-8B4F83A97B8FQ34555160-0B3F9AF2-7708-4FBF-AF9F-3A708A716E21Q34570018-2CDBC415-A170-4ADE-BE35-4F6604309425Q34580817-B041F481-A1A7-4C2C-AE74-62E803278903Q34658100-FDB08E8F-AD11-468B-8946-7035817C6811Q34679766-7F97195A-BCEE-422D-876B-66E4EA1A88DBQ34700196-A4139061-26A4-4EB4-8ED5-912A3DD087F7Q34773561-0D316943-420C-4D52-82E8-2E271849BB0FQ34801585-59EB4EF6-7EA3-4BA9-BB37-C3E18FB4C469Q34988384-178F811F-9F8A-442E-8E07-F742D4E15D78Q35087543-E208B4AA-99FB-4286-8D73-0B2C7AF2855E
P2860
Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@ast
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@en
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@en-gb
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@nl
type
label
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@ast
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@en
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@en-gb
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@nl
prefLabel
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@ast
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@en
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@en-gb
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@nl
P2093
P2860
P3181
P356
P1476
Polysubstance abuse-vulnerabil ...... ingle-nucleotide polymorphisms
@en
P2093
P2860
P304
P3181
P356
10.1086/324467
P407
P577
2001-11-06T00:00:00Z